Latest Breaking News On - Prnewswire milestone pharmaceuticals inc - Page 1 : comparemela.com

Milestone Pharmaceuticals To Present At The Piper Sandler 35Th Annual Healthcare Conference

Milestone Pharmaceuticals To Present At The Piper Sandler 35Th Annual Healthcare Conference
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerKim foxDrug administrationMilestone pharmaceuticals incAmerican heart association scientific sessionsMilestone pharmaceuticalsPrnewswire milestone pharmaceuticals incAnnual healthcare conferenceNew drug applicationFeatured science sessionVice president

Milestone Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

/PRNewswire/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that members of its management team will participate in a fireside chat at the.

United statesKim foxPiper sandlerDrug administrationMilestone pharmaceuticals incPrnewswire milestone pharmaceuticals incMilestone pharmaceuticalsAmerican heart association scientific sessionsAnnual healthcare conferenceNew drug applicationFeatured science sessionVice president

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MONTREAL and CHARLOTTE, N.C., Oct. 6, 2023 /PRNewswire/ Milestone Pharmaceuticals Inc. , today announced that the Company granted equity awards, in the form of a total of 122,000 options to.

United statesKim foxMilestone pharmaceuticals incCompany compensation committeePrnewswire milestone pharmaceuticals incMilestone pharmaceuticalsCompany or milestoneCompensation committeeNasdaq listing ruleVice president

Milestone Pharmaceuticals Announces Etripamil AFib-RVR Study is Selected for Featured Science Presentation at the American Heart Association Scientific Sessions 2023

/PRNewswire/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that results from a double-blind, randomized, placebo-controlled Phase 2.

United kingdomUnited statesCity ofDavid bharuchaKim foxMilestone pharmaceuticals incGeorge university of londonClinical sciences research instituteAmerican heart associationExchange commissionMilestone pharmaceuticalsCardiology clinical academic groupPrnewswire milestone pharmaceuticals incCenters for diseaseUs securities exchange commissionScientific sessions

Milestone Pharmaceuticals to Present at the H C Wainwright 25th Annual Global Investment Conference

/PRNewswire/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative.

United statesDavid pittsPrnewswire milestone pharmaceuticals incMilestone pharmaceuticalsMilestone pharmaceuticals incAnnual global investment conference